APO-NORFLOXACIN norfloxacin 400 mg tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-norfloxacin norfloxacin 400 mg tablet bottle

arrotex pharmaceuticals pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.

RIVA-NORFLOXACIN TABLET Canada - English - Health Canada

riva-norfloxacin tablet

laboratoire riva inc. - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

TEVA-NORFLOXACIN TABLET Canada - English - Health Canada

teva-norfloxacin tablet

teva canada limited - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

NTP-NORFLOXACIN TABLET Canada - English - Health Canada

ntp-norfloxacin tablet

teva canada limited - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

NORFLOXACIN WATSON norfloxacin 400mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

norfloxacin watson norfloxacin 400mg tablet blister pack

medis pharma pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; sodium starch glycollate; colloidal anhydrous silica; magnesium stearate; purified talc; titanium dioxide; hypromellose; macrogol 400 - indications: the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.

NORFLOXACIN ASCENT norfloxacin 400mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

norfloxacin ascent norfloxacin 400mg tablet blister pack

medis pharma pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; sodium starch glycollate; colloidal anhydrous silica; magnesium stearate; purified talc; titanium dioxide; hypromellose; macrogol 400 - indications: the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.

NORFLOXACIN-AS norfloxacin 400mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

norfloxacin-as norfloxacin 400mg tablet blister pack

medis pharma pty ltd - norfloxacin, quantity: 400 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate dihydrate; sodium starch glycollate; colloidal anhydrous silica; magnesium stearate; purified talc; titanium dioxide; hypromellose; macrogol 400 - indications: the treatment of adults with complicated and uncomplicated urinary tract infections that are caused by susceptible strains of microorganisms. the treatment of adults with gastrointestional infections, in particular shigellosis and traveller's diarrhoea. note: specimens for culture and susceptibility testing should be obtained prior to and during treatment if clinical response warrants. suppression in adults of chronic, recurrent urinary tract infections.

Arrow - Norfloxacin New Zealand - English - Medsafe (Medicines Safety Authority)

arrow - norfloxacin

teva pharma (new zealand) limited - norfloxacin 400mg;   - film coated tablet - 400 mg - active: norfloxacin 400mg   excipient: croscarmellose sodium magnesium stearate microcrystalline cellulose opadry white oy-b-28920 amb purified water - upper and lower, complicated and uncomplicated acute urinary tract infections including cystitis, pyelitis, cystopyelitis, pyelonephritis, chronic prostatitis, epididymitis, and those urinary infections associated with urologic surgery, neurogenic bladder or nephrolithiasis caused by bacteria susceptible to norfloxacin;

RIVA-NORFLOXACIN TABLET Canada - English - Health Canada

riva-norfloxacin tablet

laboratoire riva inc. - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones

PMS-NORFLOXACIN TABLET Canada - English - Health Canada

pms-norfloxacin tablet

pharmascience inc - norfloxacin - tablet - 400mg - norfloxacin 400mg - quinolones